&nbsp;

RapportRendementDepistageCancerOntario.pdf

Jan 2021

Regimen

RIPR

Cancer Type:

Gastrointestinal,

Gastrointestinal Stromal Tumours

Intent: Palliative

Funding:

Exceptional Access Program

ripretinib - For adult patients with advanced gastrointestinal stromal tumours (GIST) who have progression on or intolerance to imatinib, sunitinib and regorafenib

Drugs Used:

ripretinib

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2023

Regimen

XELOX+NIVL

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab - First-line Treatment of Advanced Gastric, Esophageal, and Esophagogastric Junction Adenocarcinoma

ODB - General Benefit

capecitabine

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Cancer facts

Rare cancers have a high impact on people

Nov 2021

Guidelines and Advice

Recommendations Report Microwave Ablation and Cryoablation

May 2021

Document

RadiationTreatment-QBP-FrequentlyAskedQuestions.pdf

Mar 2022

Regimen

XELOX+BEVA

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Funding:

ODB - General Benefit

capecitabine

New Drug Funding Program

Bevacizumab (Biosimilar) - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

XELOX

Cancer Type:

Gastrointestinal,

Colorectal,

Small bowel and appendix

Intent: Palliative

Funding:

ODB - General Benefit

capecitabine

Drugs Used:

oxaliplatin,

capecitabine

... Show more tags

Quick Link(s):

Regimen Monograph, Patient Info Sheet (XELOX)

Jan 2024

Document

RadiationTreatmentProgram23-24-EN-FR.pdf

Jul 2022

Document

RadiationTreatmentProgramSummary-FR.pdf

Nov 2022

Document